Fumihiro Sakakibara
Fumihiro Sakakibara publishes mostly in Neurology, Epidemiology and Pulmonary and Respiratory Medicine, on topics such as Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases and Intracranial Aneurysms: Treatment and Complications.
- World rank
- #3,130,012 of 7,710,434 ranked researchers
- Rank in Japan
- #71,679 of 383,136
- Works
- 87
- Citations
- 1.4k
- Citations per work
- 16.5
What does Fumihiro Sakakibara research?
Fumihiro Sakakibara's work is mostly in Medicine (85%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7484.7%
- Medicine7484.7%
- Everything else1315.3%
- 1Neurology24% of their works
- 2Epidemiology22% of their works
- 3Pulmonary and Respiratory Medicine19% of their works
- 4Cardiology and Cardiovascular Medicine9% of their works
- 5Surgery9% of their works
- 6Rehabilitation2% of their works
Research topics
- Acute Ischemic Stroke Management
- Cerebrovascular and Carotid Artery Diseases
- Intracranial Aneurysms: Treatment and Complications
- Intracerebral and Subarachnoid Hemorrhage Research
- Atrial Fibrillation Management and Outcomes
- Peripheral Artery Disease Management
- Meningioma and schwannoma management
- Vascular Malformations Diagnosis and Treatment
Which keywords describe Fumihiro Sakakibara's research?
The keywords of their largest research topics: Revascularization, Risk Factors, Stroke Prevention, Ischemic Stroke, Thrombolysis, Carotid Artery Stenosis, Endarterectomy and Endovascular Treatment.
- Genomic Analysis
- Arteriovenous Malformations
- Angioplasty
- Atrial Fibrillation
- Cerebral Amyloid Angiopathy
- Guidelines
- Aneurysmal Subarachnoid Hemorrhage
- Endovascular Treatment
- Carotid Artery Stenosis
- Ischemic Stroke
- Risk Factors
- Revascularization
- Stroke Prevention
- Thrombolysis
- Endarterectomy
- Anticoagulant Therapy
- Intracranial Aneurysms
- Radiosurgery
- Intracerebral Hemorrhage
- Catheter Ablation
- Peripheral Arterial Disease
- Cerebral Cavernous Malformations
- Meningiomas
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Revascularization552 topics
- Risk Factors552 topics
- Stroke Prevention532 topics
- Ischemic Stroke441 topic
- Thrombolysis441 topic
- Carotid Artery Stenosis411 topic
- Endarterectomy411 topic
- Endovascular Treatment332 topics
- Anticoagulant Therapy292 topics
- Aneurysmal Subarachnoid Hemorrhage241 topic
- Intracranial Aneurysms241 topic
- Guidelines232 topics
- Radiosurgery182 topics
- Cerebral Amyloid Angiopathy171 topic
- Intracerebral Hemorrhage171 topic
- Atrial Fibrillation121 topic
- Catheter Ablation121 topic
- Angioplasty111 topic
- Peripheral Arterial Disease111 topic
- Arteriovenous Malformations91 topic
- Cerebral Cavernous Malformations91 topic
- Genomic Analysis91 topic
- Meningiomas91 topic
Where does Fumihiro Sakakibara work?
Fumihiro Sakakibara's main affiliation in the publication record is Hyogo University, Japan.
How many publications and citations does Fumihiro Sakakibara have?
OpenAlex counts 87 works and 1,435 citations for Fumihiro Sakakibara, an h-index of 14, ranking #3,130,012 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fumihiro Sakakibara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.